Using the Wilcoxon test, we investigated the temporal changes in CD39 expression on Tregs and their subpopulations in a cohort of 21 patients, spanning from the acute phase of COVID-19 to the convalescent stage at 3–6 months (Figure 7). Here, ENTPD1 is linked to COVID-19.